The occurrence of new bacterial and fungal infections within 30 days after OLT was lower in matched patients who received the IgM preparation (27.3%) than in those who did not (48.5%), with an absolute risk reduction of 21.2% (p = 0.067) (see Supplemental Material, Table S3). This evidence concerns the gene CD40LG and fungal infectious disease.